Status of the clinical evaluation of levodopa in the treatment of Parkinson's disease and syndrome.
D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood; D001806:Blood Urea Nitrogen; D002986:Clinical Trials as Topic; D003863:Depression / Q000209:etiology; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000145:classification / Q000188:drug therapy*; D013997:Time Factors
D004295:Dihydroxyphenylalanine; D001219:Aspartate Aminotransferases